Umemura Shinobu, Osamura R Yoshiyuki
Department of Pathology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan.
Breast Cancer. 2004;11(4):334-8. doi: 10.1007/BF02968039.
Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.
免疫组织化学(IHC)已被用于寻找特定蛋白质产物、观察乳腺癌的独特特征、将乳腺癌与其他部位起源的癌症区分开来、获取有关基因改变的信息、研究预后因素以及为有效治疗提供预测因素。技术的发展使得将免疫组织化学用作便捷的诊断工具成为可能,并且还能将其与其他组织化学技术结合用于先进的方案中。在这篇综述文章中,将介绍免疫组织化学的发展、用于鉴别诊断的免疫组织化学以及在乳腺癌实践中用于提供有关激素受体和HER2信息的免疫组织化学。标准化和质量控制是在乳腺癌实践中充分利用免疫组织化学的关键问题。